Search research articles
Contact Us
Filters
Showing results (81-90 of 184) with videos related to
Page
of 19
Sort By:
Journal Des Maladies Vasculaires
|
June 3, 1998
[Staphylokinase and its mutants: a new generation of thrombolytic agents]
J Lebrazi, I Elalamy, G Helft, et al.
Pathologie-Biologie
|
September 24, 2005
[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases]
S Guermazi, J Conard, M M Samama, et al.
Seminars in Thrombosis and Hemostasis
|
April 1, 1985
Markers of fibrinogen derivatives used in clinical investigation
J Soria, C Soria, M Mirshahi, et al.
Thrombosis Research
|
March 15, 1986
Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor II
J Conard, L Bara, M H Horellou, et al.
Thrombosis Research
|
September 1, 1994
Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbits
D Zitoun, L Bara, M F Bloch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 26, 1998
Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis model
G Helft, L Bara, M F Bloch, et al.
Journal Des Maladies Vasculaires
|
July 27, 2010
[Perioperative use of antithrombotic agents: recommendations of the American College of Chest Physicians (ACCP) and the French Superior Health Authority (HAS)]
M M Samama, M H Horellou, A Achkar, et al.
Presse Medicale (Paris, France : 1983)
|
November 4, 1995
[Anticardiolipin antibodies and thrombosis]
S Bentolila, M H Horellou, J Conard, et al.
British Journal of Haematology
|
September 1, 1994
Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment
A Chabanel, M H Horellou, J Conard, et al.
Thrombosis and Haemostasis
|
January 1, 1995
Influence of storage conditions on activated protein C resistance assay
M Trossaërt, J Conard, M H Horellou, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 184) with videos related to
Sort By:
Page
of 19
Journal Des Maladies Vasculaires
|
June 3, 1998
[Staphylokinase and its mutants: a new generation of thrombolytic agents]
J Lebrazi, I Elalamy, G Helft, et al.
Pathologie-Biologie
|
September 24, 2005
[Type 2B and pseudo type 2B Von Willebrand disease; a report of three cases]
S Guermazi, J Conard, M M Samama, et al.
Seminars in Thrombosis and Hemostasis
|
April 1, 1985
Markers of fibrinogen derivatives used in clinical investigation
J Soria, C Soria, M Mirshahi, et al.
Thrombosis Research
|
March 15, 1986
Bovine or human thrombin in amidolytic at III assays. Influence of heparin cofactor II
J Conard, L Bara, M H Horellou, et al.
Thrombosis Research
|
September 1, 1994
Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbits
D Zitoun, L Bara, M F Bloch, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
August 26, 1998
Comparative time course of thrombolysis induced by intravenous boluses and infusion of staphylokinase and tissue plasminogen activator in a rabbit arterial thrombosis model
G Helft, L Bara, M F Bloch, et al.
Journal Des Maladies Vasculaires
|
July 27, 2010
[Perioperative use of antithrombotic agents: recommendations of the American College of Chest Physicians (ACCP) and the French Superior Health Authority (HAS)]
M M Samama, M H Horellou, A Achkar, et al.
Presse Medicale (Paris, France : 1983)
|
November 4, 1995
[Anticardiolipin antibodies and thrombosis]
S Bentolila, M H Horellou, J Conard, et al.
British Journal of Haematology
|
September 1, 1994
Red blood cell aggregability in patients with a history of leg vein thrombosis: influence of post-thrombotic treatment
A Chabanel, M H Horellou, J Conard, et al.
Thrombosis and Haemostasis
|
January 1, 1995
Influence of storage conditions on activated protein C resistance assay
M Trossaërt, J Conard, M H Horellou, et al.
Page
of 19